Officer Christian Henry Files Intent to Sell $955K in Common Stock
PACB sits 88% above its 52-week low of $0.851.
Summary
An officer of Pacific Biosciences of California, Inc. has filed a Form 144 indicating an intent to sell approximately $955,547 worth of common stock.
Key Events · Ownership and Investor Activity · PACB
-
Officer Files Intent to Sell
Christian Henry, an officer of Pacific Biosciences, has filed a Form 144 indicating an intent to sell company shares.
-
Significant Stock Sale Proposed
The filing details a proposed sale of 606,312 shares of common stock, with an approximate market value of $955,547.71.
-
Recently Acquired Restricted Stock
The shares intended for sale were acquired as restricted stock on February 15, 2026, just two days prior to the proposed sale date.
Analysis · PACB · Industrial Applications And Services
This Form 144 filing by Christian Henry, an officer of Pacific Biosciences, signals an intent to sell a notable amount of company stock. While the proposed sale represents a relatively small percentage of the company's overall market capitalization, it is a significant transaction for an individual officer. The timing, with the shares being acquired as restricted stock just two days prior to the proposed sale, suggests a potential liquidity event or a pre-planned disposition of recently vested equity. This follows recent positive news, including better-than-expected Q4 results and a significant asset sale, which could be a factor in an officer choosing to realize gains. Investors should monitor subsequent Form 4 filings to confirm the actual sale and its impact.
At the time of this filing, PACB was trading at $1.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $477M. The 52-week trading range was $0.85 to $2.73. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.